UNC Lineberger News

Sharpless and Kim inducted at American Association of Physicians and American Society for Clinical Investigation meeting, Rathmell elected ASCI Treasurer

Norman Sharpless, MD, Director of the UNC Lineberger Comprehensive Cancer Center has been inducted as a member of the American Association of Physicians (AAP). His induction was announced at the joint American Society for Clinical Investigation (ASCI)/American Association of Physicians meeting in Chicago.

Sharpless and Kim inducted at American Association of Physicians and American Society for Clinical Investigation meeting, Rathmell elected ASCI Treasurer - Read More…

UNC Lineberger selected to join A Survivor Action Partnership to improve the lives of prostate cancer survivors

UNC Lineberger selected to join A Survivor Action Partnership to improve the lives of prostate cancer survivors

UNC Lineberger has been selected to participate in A Survivor Action Partnership – United States of America (ASAP USA), a consortium of institutions that will collaborate to develop and study interventions to improve the lives of prostate cancer survivors in the United States. Sixteen institutions were selected following a peer reviewed application process. Ronald Chen, MD, MPH, assistant professor of radiation oncology is leading the UNC Lineberger ASAP USA team.

UNC Lineberger selected to join A Survivor Action Partnership to improve the lives of prostate cancer survivors - Read More…

UNC Lineberger’s Matt Foster, MD, vies for the Leukemia & Lymphoma Society's Man of the Year title

The Leukemia & Lymphoma Society's Man & Woman of the Year (MWOY) campaign is a national fundraising competition in which participants vie for the title of Man or Woman of the Year. They raise funds for blood cancer research in honor of local children who are blood cancer survivors. The titles are awarded to the men and women who raise the most funds during the campaign in their communities. The top local fundraisers in the country also win the national titles.

UNC Lineberger’s Matt Foster, MD, vies for the Leukemia & Lymphoma Society's Man of the Year title - Read More…

Solving Cancer’s Secrets: 5 Questions with Dr. Chuck Perou

Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer

Solving Cancer’s Secrets: 5 Questions with Dr. Chuck Perou - Read More…

UNC researchers develop insights into protein linked to cell movement

Cell movement plays an important role in a host of biological functions from embryonic development to repairing wounded tissue. It also enables cancer cells to break free from their sites of origin and migrate throughout the body.

UNC researchers develop insights into protein linked to cell movement - Read More…

Mayer Receives Funds to Implement Survivorship Care Plans

Mayer Receives Funds to Implement Survivorship Care Plans

UNC Lineberger member Deborah K. Mayer, PhD, RN, AOCN, FAAN, was awarded $50,000 in funding through the UNC School of Medicine’s Institute for Healthcare Quality Improvement seed grant program for her proposal “Implementing Survivorship Care Plans.”

Mayer Receives Funds to Implement Survivorship Care Plans - Read More…

Andrew Tucker: Building a Better Image

Andrew Tucker, PhD, used his graduate experience at UNC to help build a new kind of mammographic imaging machine now in use in a clinical trial at the North Carolina Cancer Hospital.

Andrew Tucker: Building a Better Image - Read More…

Pope Foundation gives $1.3 million to UNC Lineberger to fight cancer

The John William Pope Foundation has made a $1.3 million gift to UNC Lineberger Comprehensive Cancer Center to fund cancer research and treatment.

Pope Foundation gives $1.3 million to UNC Lineberger to fight cancer - Read More…

Johnson joins ‘Dream Team’ of scientists  collaborating on rare pediatric cancer

Johnson joins ‘Dream Team’ of scientists collaborating on rare pediatric cancer

UNC Lineberger member Gary Johnson, PhD, professor and chair of the UNC Department of Pharmacology, has been tapped to join Synodos, a team of scientists working together to defeat the rare genetic disorder neurofibromatosis type 2 (NF2). A first-of-its-kind NF research collaboration, Synodos has brought together centers of excellence from institutions across the country. Johnson will be just one of 12 academic researchers in the collaboration.

Johnson joins ‘Dream Team’ of scientists collaborating on rare pediatric cancer - Read More…